Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy.
Angelopoulou A, Theocharous G, Valakos D, Polyzou A, Magkouta S, Myrianthopoulos V, Havaki S, Fiorillo M, Tremi I, Vachlas K, Nisotakis T, Thanos DF, Pantazaki A, Kletsas D, Bartek J, Petty R, Thanos D, McCrimmon RJ, Papaspyropoulos A, Gorgoulis VG.
Angelopoulou A, et al. Among authors: fiorillo m.
Mol Cancer. 2024 Jul 25;23(1):147. doi: 10.1186/s12943-024-02061-4.
Mol Cancer. 2024.
PMID: 39048991
Free PMC article.